Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Mossa F, Robesti D, Sumankalai R, Corey E, Titus M, Kang Y, Zhang J, Briganti A, Montorsi F, Vellano CP, Marszalek JR, Frigo DE, Logothetis CJ, Gujral TS, Dondossola E. Mossa F, et al. Among authors: corey e. Mol Cancer Res. 2023 Jan 3;21(1):51-61. doi: 10.1158/1541-7786.MCR-22-0250. Mol Cancer Res. 2023. PMID: 36112348 Free PMC article.
Osteoprotegerin in prostate cancer bone metastasis.
Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Corey E, et al. Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033. Cancer Res. 2005. PMID: 15753366
Role of WNT7B-induced noncanonical pathway in advanced prostate cancer.
Zheng D, Decker KF, Zhou T, Chen J, Qi Z, Jacobs K, Weilbaecher KN, Corey E, Long F, Jia L. Zheng D, et al. Among authors: corey e. Mol Cancer Res. 2013 May;11(5):482-93. doi: 10.1158/1541-7786.MCR-12-0520. Epub 2013 Feb 5. Mol Cancer Res. 2013. PMID: 23386686 Free PMC article.
Androgen receptor splice variants determine taxane sensitivity in prostate cancer.
Thadani-Mulero M, Portella L, Sun S, Sung M, Matov A, Vessella RL, Corey E, Nanus DM, Plymate SR, Giannakakou P. Thadani-Mulero M, et al. Among authors: corey e. Cancer Res. 2014 Apr 15;74(8):2270-2282. doi: 10.1158/0008-5472.CAN-13-2876. Epub 2014 Feb 20. Cancer Res. 2014. PMID: 24556717 Free PMC article.
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer.
Corella AN, Cabiliza Ordonio MVA, Coleman I, Lucas JM, Kaipainen A, Nguyen HM, Sondheim D, Brown LG, True LD, Lee JK, MacPherson D, Nghiem P, Gulati R, Morrissey C, Corey E, Nelson PS. Corella AN, et al. Among authors: corey e. Clin Cancer Res. 2020 Apr 1;26(7):1667-1677. doi: 10.1158/1078-0432.CCR-19-0775. Epub 2019 Dec 5. Clin Cancer Res. 2020. PMID: 31806643 Free PMC article.
Targeting RET Kinase in Neuroendocrine Prostate Cancer.
VanDeusen HR, Ramroop JR, Morel KL, Bae SY, Sheahan AV, Sychev Z, Lau NA, Cheng LC, Tan VM, Li Z, Petersen A, Lee JK, Park JW, Yang R, Hwang JH, Coleman I, Witte ON, Morrissey C, Corey E, Nelson PS, Ellis L, Drake JM. VanDeusen HR, et al. Among authors: corey e. Mol Cancer Res. 2020 Aug;18(8):1176-1188. doi: 10.1158/1541-7786.MCR-19-1245. Epub 2020 May 27. Mol Cancer Res. 2020. PMID: 32461304 Free PMC article.
637 results